Publications by authors named "T R Halfdanarson"

Claim this Profile
O
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.
Cody Eslinger, Daniel Walden, Alexandra Krivonos, Numrah Fadra, Tyler Zemla, Thorvardur Halfdanarson

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The overarching prognostic role of tumor progression prior to cytoreductive hepatectomy in NETLM.
Vanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, Yawen Dong, Jonas Santol, Thorvardur R Halfdanarson

Eur J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center Study.
Vanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, Yawen Dong, Cornelius A Thiels, Thorvardur R Halfdanarson

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center Analysis.
Vanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, Yawen Dong, Jonas Santol, Thorvardur R Halfdanarson

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Peptide Receptor Radionuclide Therapy with Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jolanta M Durski, Ann T Packard, Thorvardur R Halfdanarson

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis